Immunotherapy for older patients with cancer.
Tatianny P Araujo VargasAbdullah Al-HumiqaniDanilo Giffoni De Mello Morais MataInes B MenjakPublished in: Current opinion in supportive and palliative care (2023)
Older adults remain underrepresented in clinical trials, including those involving immunotherapy. Therefore, efforts must be made to include more older patients in trials and to assess real-world evidence to inform decision-making.